Avadel Pharmaceuticals plc's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026When a company is bought, its stock stops trading and shareholders receive payment instead of owning shares.
Court approval is required before the deal can close, making this an important step toward the acquisition completing.
Stocky reads Avadel Pharmaceuticals plc's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Avadel Pharmaceuticals plc's most recent tracked filing was a 8-K on 12 Feb 2026: Avadel acquired by Alkermes, shares delisted from Nasdaq.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.